NEO· Neogenomics Inc.
Insider buys/sells · last 6 mo · open market only
| Transactions | Total $ | |
|---|---|---|
| Buys | 0 | $0 |
| Sells | 0 | $0 |
Quarterly ownership history
Last 6 quarters
NEO Financials
Live via yfinance — refreshed daily.
Valuation
Market capitalization$1.2B
Enterprise value$1.4B
EV / EBITDA (TTM)334.92
P/E ratio (TTM)—
Forward P/E24.58
P/S ratio1.56
P/B ratio1.38
PEG ratio—
Cash Flow
Operating cash flow (TTM)$22M
Free cash flow (TTM)$33M
Total cash$146M
Total debt$409M
Debt / equity49.29
Current ratio4.42
Income Statement
Total revenue (TTM)$746M
Revenue per share (TTM)5.80
Gross profit (TTM)$322M
EBITDA (TTM)$4M
Net income (TTM)-$99M
EPS diluted (TTM)-0.77
Shares outstanding130,211,780
Float shares118,895,074
Profitability
Gross margin43.10%
Operating margin-9.34%
EBITDA margin0.57%
Net margin-13.30%
Efficiency
Return on assets (TTM)-2.64%
Return on equity (TTM)-11.56%
Price History
Current price$8.96
52 Week high$13.74
52 Week low$4.72
50 day average$8.40
200 day average$9.48
Average volume (10 day)3,006,000
1-year beta1.80
1-year price target$15.06
Dividends
Dividend yield—
Dividend rate (annual)—
Payout ratio0.00%
Fundamentals are sourced from yfinance and refreshed daily. Last updated May 10, 2026, 5:40 PM. Empty cells (—) mean yfinance doesn't have that field for this ticker (common for ADRs, recent IPOs, or non-applicable ratios).
Real-time alerts. We'll let you know when a whale you follow files a new 13F, or a stock you follow has insider activity. No weekly digest.
whalstreet
★ WatchlistData from SEC EDGAR · whalstreet.com